Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Gibson

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Parkinsonism & Related Disorders|April 3, 2007
Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's diseaseOwen A Ross, Kristoffer Haugarvoll, Jeremy T Stone, et al.
Journal of Wildlife Diseases|May 15, 2007
The elimination of raccoon rabies from Wolfe Island, Ontario: animal density and movementsRick Rosatte, Erin MacDonald, Kirk Sobey, et al.
Neuroreport|September 28, 2002
A novel polymorphic triplet repeat in intron five of the alpha-synuclein gene: no evidence of expansion or allelic association with idiopathic Parkinson's disease in the IrishOwen A Ross, Nuri H Awayn, Deborah McWhinney, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Substituent-based Modulation of Self-Assembly and Immunogenicity of Amphipathic PeptidesAnirban Das, Ushasi Pramanik, Elise M Brown, et al.
Rheumatology Advances in Practice|January 15, 2026
Development of a clinical tool to identify patients with early inflammatory arthritis at high risk of employment loss: analysis from the National Early Inflammatory Arthritis AuditEd Alveyn, Katie Bechman, Maryam Adas, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 19, 2007
ELAVL4, PARK10, and the CeltsKristoffer Haugarvoll, Mathias Toft, Owen A Ross, et al.
The Lancet Regional Health. Europe|April 18, 2025
Incidence, prevalence, and mortality of sarcoidosis in England: a population-based studyKatie Bechman, Mark D Russell, Kathryn Biddle, et al.
Rheumatology (Oxford, England)|November 1, 2024
Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort studyMark D Russell, Zijing Yang, Niamh Dooley, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 21, 2026
Substituent-Based Modulation of Self-Assembly and Immunogenicity of Amphipathic PeptidesAnirban Das, Ushasi Pramanik, Elise M Brown, et al.
The Lancet. Rheumatology|October 18, 2024
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort studyMark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Parkinsonism & Related Disorders|April 3, 2007
Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's diseaseOwen A Ross, Kristoffer Haugarvoll, Jeremy T Stone, et al.
Journal of Wildlife Diseases|May 15, 2007
The elimination of raccoon rabies from Wolfe Island, Ontario: animal density and movementsRick Rosatte, Erin MacDonald, Kirk Sobey, et al.
Neuroreport|September 28, 2002
A novel polymorphic triplet repeat in intron five of the alpha-synuclein gene: no evidence of expansion or allelic association with idiopathic Parkinson's disease in the IrishOwen A Ross, Nuri H Awayn, Deborah McWhinney, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Substituent-based Modulation of Self-Assembly and Immunogenicity of Amphipathic PeptidesAnirban Das, Ushasi Pramanik, Elise M Brown, et al.
Rheumatology Advances in Practice|January 15, 2026
Development of a clinical tool to identify patients with early inflammatory arthritis at high risk of employment loss: analysis from the National Early Inflammatory Arthritis AuditEd Alveyn, Katie Bechman, Maryam Adas, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 19, 2007
ELAVL4, PARK10, and the CeltsKristoffer Haugarvoll, Mathias Toft, Owen A Ross, et al.
The Lancet Regional Health. Europe|April 18, 2025
Incidence, prevalence, and mortality of sarcoidosis in England: a population-based studyKatie Bechman, Mark D Russell, Kathryn Biddle, et al.
Rheumatology (Oxford, England)|November 1, 2024
Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort studyMark D Russell, Zijing Yang, Niamh Dooley, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 21, 2026
Substituent-Based Modulation of Self-Assembly and Immunogenicity of Amphipathic PeptidesAnirban Das, Ushasi Pramanik, Elise M Brown, et al.
The Lancet. Rheumatology|October 18, 2024
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort studyMark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
Pageof 13